David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
PUT
Workday
WDAY
$49.4B
| $70.1M | 0.06% |
253,900
+10,000
| +4% | +$2.38M |
|
352
CALL
RH
RH
$2.9B
| $69.9M | 0.06% |
239,800
+41,300
| +21% | +$10.7M |
|
353
PUT
Bristol-Myers Squibb
BMY
$137B
| $69.9M | 0.06% |
1,362,100
-269,400
| -17% | -$14.1M |
|
354
CALL
Enbridge
ENB
$110B
| $69.5M | 0.06% |
1,930,000
+1,519,600
| +370% | +$51.2M |
|
355
PUT
Moderna
MRNA
$57.9B
| $69.4M | 0.06% |
697,400
+190,100
| +37% | +$16M |
|
|
356
CALL
Moderna
MRNA
$57.9B
| $69.3M | 0.06% |
696,400
+64,100
| +10% | +$5.39M |
|
357
Archer Daniels Midland
ADM
$38.7B
| $69.2M | 0.06% |
957,633
+163,719
| +21% | +$12M |
|
358
CALL
Rivian
RIVN
$24.6B
| $69M | 0.06% |
2,941,800
+540,000
| +22% | +$10.2M |
|
359
PUT
Lam Research
LRCX
$393B
| $67.9M | 0.06% |
867,000
+213,000
| +33% | +$14.5M |
|
360
Stryker
SYK
$126B
| $67.8M | 0.06% |
226,329
+176,413
| +353% | +$49.5M |
|
361
Boeing
BA
$169B
| $67.7M | 0.06% |
259,668
+250,468
| +2,722% | +$53.6M |
|
362
Qorvo
QRVO
$8.43B
| $67.2M | 0.06% |
597,025
+89,639
| +18% | +$8.65M |
|
363
Datadog
DDOG
$84.6B
| $67.1M | 0.06% |
552,618
+438,461
| +384% | +$45.2M |
|
364
Valmont Industries
VMI
$9.38B
| $67.1M | 0.06% |
287,145
+24,934
| +10% | +$5.48M |
|
365
PUT
NextEra Energy
NEE
$174B
| $66.6M | 0.06% |
1,095,900
+669,400
| +157% | +$38.1M |
|
366
Elanco Animal Health
ELAN
$12B
| $66.4M | 0.06% |
4,454,976
-635,685
| -12% | -$7.2M |
|
367
PUT
Affirm
AFRM
$25.8B
| $66.4M | 0.06% |
1,350,500
+841,600
| +165% | +$24.3M |
|
368
PUT
AbbVie
ABBV
$468B
| $66.2M | 0.06% |
427,100
+125,700
| +42% | +$18.3M |
|
369
Spotify
SPOT
$110B
| $65.6M | 0.06% |
349,060
-100,861
| -22% | -$17.6M |
|
370
PUT
Starbucks
SBUX
$122B
| $65.4M | 0.06% |
680,700
+312,300
| +85% | +$30.4M |
|
371
argenx
ARGX
$65B
| $65M | 0.06% |
170,746
-40,540
| -19% | -$18.9M |
|
372
CALL
Palantir
PLTR
$432B
| $64.8M | 0.06% |
3,774,500
+57,900
| +2% | +$1.03M |
|
373
PUT
IBM
IBM
$222B
| $64.7M | 0.06% |
395,300
+58,200
| +17% | +$8.79M |
|
374
CALL
Zscaler
ZS
$29.4B
| $64M | 0.06% |
288,900
+105,600
| +58% | +$19.6M |
|
|
375
CALL
NextEra Energy
NEE
$174B
| $64M | 0.06% |
1,053,300
+26,700
| +3% | +$1.52M |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.